HALPERN JOHN D purchased 292.0% of their position (335.92K shares) of ERNEXA THERAPEUTICS INC. on the open market
Open‑market purchase worth $1.10M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/5/2022ACC: 0001062993-22-023351
+1.01M
Net shares
Net buyer
$1.10M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
1.01M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+335.92K
Price / share
$3.28
Trade value
$1.10M
% of position
292.0%
12/2/2022
115.04K→450.96K
Total
Net shares
+335.92K
Net value
$1.10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/2/2022 | P · Purchase | +335.92K | $3.28 | $1.10M | 292.0% | 115.04K | 450.96K |
| Total | +335.92K | $1.10M | ||||||
Derivative Transactions1
Warrants (Right to Purchase)
Indirect
Converts to
Common Stock
671.84K shares
Shares
+671.84K
Strike price
3.28
Held after
671.84K
Exercisable
—
12/2/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (Right to Purchase) Indirect | Common Stock671.84K shares | 12/2/2022 | P · Purchase | +671.84K | 3.28 | — | 671.84K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned205.00
Total
205.00 direct205.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 205.00 | Direct |
| Total | 205.00 | 205.00 direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported